[Chemotherapy-induced peripheral neuropathy: characteristics, diagnosis and treatment]. / Kemoterápia okozta szenzoros neuropátiák jellegzetességei, diagnosztikája és kezelése.
Magy Onkol
; 60(2): 165-75, 2016 06 06.
Article
em Hu
| MEDLINE
| ID: mdl-27275643
ABSTRACT
Longer remissions and better overall survival rates can be achieved with the introduction of new, effective treatments and targeted therapies in the past 1-2 decades, however, the incidence of side effects is also increasing parallelly. Chemotherapy-induced peripheral neuropathy (CIPN) is a common and potentially debilitating side effect due to peripheral somatic or autonomic nerve dysfunction. CIPN becomes increasingly important, as it affects patients' quality of life, and it is very often a dose limiting factor with the potential for reduced treatment efficacy. The pathomechanism, diagnosis, prevention and treatment possibilities are described in this review with special attention to the different groups of drugs.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Qualidade de Vida
/
Doenças do Sistema Nervoso Periférico
/
Antineoplásicos
Tipo de estudo:
Diagnostic_studies
/
Incidence_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
Hu
Ano de publicação:
2016
Tipo de documento:
Article